AEVIS VICTORIA SA / Key word(s): Annual Results/Interim Report
27-Feb-2019 / 17:45 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.
Fribourg, 27 February 2019
AEVIS VICTORIA SA achieved a 8.7% increase in revenues to CHF 186 million (2017: 172 million) in the fourth quarter of 2018
In the last quarter of 2018, AEVIS VICTORIA SA reversed the downward trend that started in 2017. At Swiss Medical Network in particular, the growth of certain units as well as the acquisitions of Siloah and Medical Centres in Solothurn and Zurich-Oerlikon have made it possible to offset tariffs reductions and temporary closures for renovation works.
For the full 2018 financial year, AEVIS VICTORIA expects sales of CHF 656 million, down 1.1% on the previous year (2017: CHF 663 million). Net revenue amounted to CHF 576 million (2017: CHF 583 million). This slight decrease is due to the complete closure for renovation of the Hotel Eden au Lac in Zurich, the partial closure for renovation work in three hospitals and to a lesser extent the reduction in TARMED tariffs. Excluding these exceptional factors, business grew in most of the Group’s entities.
The sale of a 20% stake in Infracore SA to Baloise enabled AEVIS VICTORIA SA to realize a financial gain of nearly CHF 77 million in Q4 2018. This gain will not be reflected in the consolidated profit and loss statement because it concerns the sale of a minority stake. However, the transaction will contribute to strengthening the Group’s consolidated shareholders’ equity at the end of 2018.
AEVIS VICTORIA will report 2018 full-year results on 29 March 2019.
For further information:
AEVIS VICTORIA SA – Investing for a better life
End of ad hoc announcement